Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

About

News & Events

News

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center 

02.19.25

Celerion Pledges Commitment to the Science-Based Targets Initiative (SBTi) Net-Zero Standard

12.04.24

Celerion’s US Pharmacies Expand On-Site Services, Ensure cGMP FDA Compliance for Phase 1 Investigational Drugs

07.17.24

All News

Events

EIP 2025

02.24.2025 - 02.26.2025

Boston Society Gene & Cell Therapy Conference

03.20.2025 - 03.21.2025

WRIB 2025

04.07.2025 - 04.11.2025

All Events

Blog Posts

GLP-1 Agonist-Induced Delayed Gastric Emptying – A Clinical Pharmacology Perspective

11.05.24

How Healthy Volunteer Studies can Accelerate Oncology Drug Development

09.11.24

Key Clinical Pharmacology Studies to Support Biologic Drug Regulatory Submission

05.22.24

All Blog Posts